Canis ISSN: 2398-2942

Clemastine

Contributor(s): Rosanna Marsella, Vetstream Ltd

Introduction

Class of drug

  • Antihistamine, H1 blocker.

Description

Storage requirements

  • Tight, light-resistant containers.

Uses

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Indications

  • Management of allergic disease.

Administration

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Precautions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Interactions

with other drugs

Adverse Reactions

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Hansson H, Bergvall K, Bondesson U et al (2004) Clinical pharmacology of clemastine in healthy dogs. Vet Derm 15 (3), 152-158 PubMed.
  • García G, DeMora F, Ferrer L et al (1997) Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells. Am J Vet Res 58 (3), 293-297 PubMed.
  • Paterson S (1995) Additive benefits of EFA's in dogs with atopic dermatitis after partial response to antihistamine therapy. JSAP 36 (9), 389-394 PubMed.

Other sources of information

  • Plumb Veterinary Drug handbook 3 edn. pp 167-168.

ADDED